Focus Partners Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$173M Buy
1,435,704
+8,160
+0.6% +$942K 0.19% 117
2025
Q4
$150M Buy
1,427,544
+191,758
+16% +$18M 0.17% 117
2025
Q3
$104M Buy
1,235,786
+22,132
+2% +$1.82M 0.17% 119
2025
Q2
$96.1M Buy
1,213,654
+22,478
+2% +$1.79M 0.21% 103
2025
Q1
$107M Buy
1,191,176
+60,866
+5% +$5.68M 0.27% 77
2024
Q4
$112M Buy
1,130,310
+119,867
+12% +$12.4M 0.29% 68
2024
Q3
$115M Buy
1,010,443
+149,577
+17% +$17.8M 0.37% 61
2024
Q2
$107M Buy
860,866
+66,578
+8% +$8.58M 0.36% 68
2024
Q1
$105M Buy
794,288
+271,718
+52% +$33.5M 0.85% 22
2023
Q4
$57M Buy
+522,570
New +$54.2M 0.75% 23

Other funds holding MRK

Focus Partners Wealth's MRK Position: Q1 2026 in Review

Focus Partners Wealth increased its Merck (MRK) stake by 0.57% in Q1 2026, buying an estimated $942K and bringing the position to 1,435,704 shares worth $173M. The position accounts for 0.19% of the portfolio, ranked #117.

Focus Partners Wealth first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Focus Partners Wealth held 1,435,704 shares of Merck worth $173M as of Q1 2026.
  • Focus Partners Wealth bought 8,160 Merck shares in Q1 2026, an estimated $942K.
  • Merck made up 0.19% of Focus Partners Wealth's portfolio in Q1 2026, its #117 holding.
  • Focus Partners Wealth first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.